Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHA:605199)

China flag China · Delayed Price · Currency is CNY
6.80
+0.16 (2.41%)
Feb 4, 2026, 3:00 PM CST
-58.28%
Market Cap2.72B -64.7%
Revenue (ttm)1.06B -31.4%
Net Income-168.12M
EPS-0.45
Shares Out400.11M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume4,857,700
Average Volume5,111,179
Open6.68
Previous Close6.64
Day's Range6.65 - 6.83
52-Week Range6.50 - 19.10
Beta0.55
RSI33.01
Earnings DateApr 30, 2026

About SHA:605199

Hainan Huluwa Pharmaceutical Group Co., Ltd. research, develops, produces, and sells drugs in the areas of Children's digestive system, respiratory system, anti-infection, anti-virus and other fields in China. The company offers pediatrics, gynecology, antibiotics, respiratory, digestive system, cardiovascular and cerebrovascular, nourishment, and other medicine products. Hainan Huluwa Pharmaceutical Group Co., Ltd. was founded in 2005 and is based in Haikou, China. [Read more]

Sector Healthcare
Founded 2005
Employees 2,103
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 605199
Full Company Profile

Financial Performance

Financial Statements